Scarica l'app Stockscreener
2.35
1.29%
0.03
Pre-mercato:
2.37
0.02
+0.85%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.32
Aprire:
$2.32
Volume 24 ore:
1.57M
Relative Volume:
0.55
Capitalizzazione di mercato:
$805.05M
Reddito:
$796.85M
Utile/perdita netta:
$30.44M
Rapporto P/E:
27.91
EPS:
0.0842
Flusso di cassa netto:
$93.88M
1 W Prestazione:
+8.80%
1M Prestazione:
+5.86%
6M Prestazione:
-39.74%
1 anno Prestazione:
-47.19%
Intervallo 1D:
$2.29
$2.38
Intervallo di 1 settimana:
$2.06
$2.38
Portata 52W:
$1.77
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.35 | 805.05M | 796.85M | 30.44M | 93.88M | 0.0842 |
VEEV
Veeva Systems Inc
|
167.69 | 27.39B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
54.42 | 9.76B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
45.80 | 8.85B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
84.53 | 7.14B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
25.32 | 4.85B | 1.10B | 112.09M | 283.19M | 0.6096 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2026-01-22 | Downgrade | Jefferies | Buy → Hold |
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
GoodRx rallies as Wegovy HD rollout targets self-pay market - MSN
What's going on with GoodRx stock Thursday? - MSN
Why GoodRx (GDRX) Stock Is Up Today - Yahoo Finance
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity - Stock Titan
GoodRx (GDRX) director Wendy Lynn Barnes converts RSUs and uses 120,456 shares for taxes - Stock Titan
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market - Benzinga
A higher-dose Wegovy now costs $399 a month through GoodRx - Stock Titan
GoodRx Holdings (GDRX) price target decreased by 38.27% to 2.87 - MSN
Gains Report: What is the next catalyst for GoodRx Holdings IncWeekly Trade Recap & High Accuracy Swing Trade Signals - baoquankhu1.vn
Nasdaq Moves: How does GoodRx Holdings Inc perform in inflationary periods2026 Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
GDRX News | GOODRX HOLDINGS INC-CLASS A (NASDAQ:GDRX) - ChartMill
What's Going On With GoodRx Stock Thursday? - Benzinga
GoodRx brings Lilly's new weight-loss pill to pharmacies nationwide - Stock Titan
CEO Change: Will GoodRx Holdings Inc stock recover after earnings2026 Review & Risk Managed Investment Entry Signals - baoquankhu1.vn
Guidance Update: Can GoodRx Holdings Inc expand its profit margins2026 Institutional & Weekly High Conviction Trade Ideas - baoquankhu1.vn
GoodRx Holdings, Inc. (GDRX) stock price, news, quote and history - Yahoo Finance UK
Hims & Hers Advances a Consumer-Centric Digital Health Platform - TradingView — Track All Markets
3 Promising Penny Stocks With Market Caps Under $2B - simplywall.st
GDRX PE Ratio & Valuation, Is GDRX Overvalued - Intellectia AI
GoodRx Holdings, Inc. Files Form 8-K Current Report with SEC – Company Information & Key Details - Minichart
GDRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
GoodRx Holdings announces board changes following director resignation By Investing.com - Investing.com South Africa
GoodRx Holdings announces board changes following director resignation - investing.com
GoodRx Reshapes Board After Director Resignation and Reclassification - TipRanks
GoodRx's Ian T. Clark resigns from Board; Wendy Barnes shifted between classes - TradingView
Director departs as GoodRx (GDRX) rebalances board classes and terms - Stock Titan
Wall Street Recap: Is GoodRx Holdings Inc showing insider buyingStock Surge & Weekly Return Optimization Plans - baoquankhu1.vn
GoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest Update - MarketBeat
GDRX SEC FilingsGoodrx Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Movement Recap: Whats the MACD signal for GoodRx Holdings Inc2026 Volatility Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
GoodRx Holdings, Inc. Files Form 8-K with SEC – Company Details, Stock Information, and Contact Data 23418195152 - Minichart
GoodRx Chief Accounting Officer Resigns for New Opportunity - The Globe and Mail
GoodRx chief accounting officer Romin Nabiey to resign effective April 3 - Investing.com Australia
GoodRx chief accounting officer resigns to pursue other opportunities - StreetInsider
GoodRx's Romin Nabiey to Resign as Chief Accounting Officer, Effective April 3, 2026 - TradingView
GoodRx Holdings, Inc. Announces the Resignation of Romin Nabiey as Chief Accounting Officer, Effective April 3, 2026 - marketscreener.com
GoodRx (NASDAQ: GDRX) CAO Romin Nabiey to depart in 2026 - Stock Titan
GoodRx (GDRX): Vanguard disaggregates holdings after Jan 12, 2026 realignment - Stock Titan
How The Reset In Expectations Is Reframing The GoodRx Holdings (GDRX) Investment Story - Yahoo Finance
If You Invested $1,000 in Goodrx Holdings, Inc. (GDRX) - Stock Titan
Dow Update: Can GoodRx Holdings Inc expand its profit margins2026 Final Week & Weekly Hot Stock Watchlists - baoquankhu1.vn
GoodRx Holdings, Inc.(NasdaqGS: GDRX) dropped from NASDAQ Internet Index - marketscreener.com
GoodRx Holdings, Inc. Announces Dismissal of PwC as Independent Auditor in March 2026 - Minichart
GoodRx (GDRX) replaces PwC with KPMG as independent auditor for 2026 - Stock Titan
Morgan Stanley favors GoodRx (GDRX) and healthcare tech over managed care for 2026 citing strong market-beating potential - msn.com
GoodRx stock ticks up after launching weight-loss subscription service - MSN
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Strategy Pivot Hits GoodRx - Los Angeles Business Journal
Lakewood Capital Management LP Decreases Position in GoodRx Holdings, Inc. $GDRX - MarketBeat
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Goodrx Holdings Inc Azioni (GDRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | 10% Owner |
Oct 15 '25 |
Sale |
4.00 |
23,771 |
95,103 |
0 |
0.26%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):